Partner Headlines - SLXP

  1. Must Watch Stocks for Today

    Benzinga
  2. Earnings Scheduled For March 2, 2015

    Benzinga
  3. Jazz Pharmaceuticals Tops Q4 Earnings And Tests Buy Point

    IBD
  4. Biotech Pharmacyclics Spikes On Buyout Rumors

    IBD
  5. Here's Why CRT Capital Boosted Valeant Pharmaceuticals' Price ...

    Benzinga
  6. Valeant Pharmaceuticals Is Kicking Butt, Says Canaccord Genuity

    Benzinga
  7. Lannett Joins Big-Game Hunt For Drugmaker Acquisitions

    IBD
  8. Firms Bullish On Valeant Following Earnings, Acquisition

    Benzinga
  9. Valeant Pharmaceuticals Finally Zeros In On Salix Pharmaceuticals

    GuruFocus
  10. Benzinga's Top Downgrades

    Benzinga
  11. UBS Downgrades Salix Pharmaceuticals To Neutral

    Benzinga
  12. 4 Pictures Every Valeant-Salix Investor Should See

    Benzinga
  13. Taxes Put U.S. Firms On Sale

    IBD
  14. Tax System Gives Edge To Foreign Buys Of U.S. Firms

    IBD
  15. Bristol-Myers goes for the gut

    IBD
  16. Nasdaq Stretches Win Streak To 9 Days

    IBD
  17. Nasdaq Climbs As Apple Stock Hits New High

    IBD
  18. Biotech Stocks Moving Higher

    Benzinga
  19. Fast Money Halftime Report Final Trade From February 23

    Benzinga
  20. Drugmaker Mylan Takes Part In Pharma Feeding Frenzy

    IBD
  21. JMP Securities Comments On Salix Pharmaceutical's Takeover Valuation

    Benzinga
  22. Valeant CEO Explains Why The Company Is Acquiring Salix For $1 ...

    Benzinga
  23. Stocks Quietly Lower; Domino's, Medivation Break Out

    IBD
  24. Stocks Edge Lower, Oil Falls, But Managed-Care Firms Shine

    IBD
  25. Cramer: Valeant's Stock Doesn't Stop Here, It Goes Higher

    Benzinga
  26. Stocks Open Quietly in The Red; Nationstar, Valeant, Tower Rise

    IBD
  27. Benzinga's Volume Movers

    Benzinga
  28. Morning Market Gainers

    Benzinga
  29. Stock Futures Dip, But Not Much; Valeant, Polypore, AerCap Surge

    IBD
  30. Piper Jaffray Downgrades Salix Pharmaceuticals To Neutral

    Benzinga
  31. Benzinga's Top Downgrades

    Benzinga
  32. US Stock Futures Slip Ahead Of Economic Data

    Benzinga
  33. Must Watch Stocks for Today

    Benzinga
  34. Fast Money Halftime Report Final Trade From February 20

    Benzinga
  35. Valeant Pharmaceuticals Will Buy Salix For $14.5 Billion

    IBD
  36. Benzinga's Weekend M&A Chatter

    Benzinga
  37. John Paulson's Top Buys

    GuruFocus
  38. A Look At 5 IBD 50 Stocks With Upcoming Earnings

    IBD
  39. Valeant Pharmaceuticals

    IBD
  40. Great Stocks Often Have Smooth, Symmetrical Bases

    IBD
  41. Stocks Cap Short Week With Gains; Salix Up On Buyout Hopes

    IBD
  42. Greek Deal Lifts Nasdaq Near Dot-Com Bubble High

    IBD
  43. Boeing Lifts Dow; Nasdaq Gets Apple Boost

    IBD
  44. Market Turns Positive As Stocks Stage Reversal

    IBD
  45. Medical Stocks Rise; Valeant Said To Be Near Buy Of Salix

    IBD
  46. Novo Nordisk Pops On Successful Diabetes Drug Trial

    IBD
  47. John Paulson Chooses Energy, Semiconductor and Drug Stocks in ...

    GuruFocus
  48. Fourth-Quarter Acquisitions Rearrange Jana Partners' Portfolio

    GuruFocus
  49. Paulson & Company's Q4 Moves: Healthcare And Beyond

    Benzinga
  50. Benzinga's Weekend M&A Chatter

    Benzinga
  51. Three Pharma Majors In The Run To Acquire Salix

    GuruFocus
  52. Salix, Top Drug Stocks Rally As Merger Mania Heats Up

    IBD
  53. Sterne Agee Dives Deep Into 3 Biotechs

    Benzinga
  54. Benzinga's M&A Chatter for Thursday February 12, 2015

    Benzinga
  55. Volume Rises As Stocks Trade Near Session High

    IBD
  56. Shire Moves Higher On NPS Potential; Q4 Earnings Miss

    IBD
  57. Benzinga's M&A Chatter for Tuesday February 3, 2015

    Benzinga
  58. Valeant Could Be Interested In Buying Salix; Sterne Agree Says ...

    Benzinga
  59. Stocks On Pace For Second Straight Gain; Salix Rallies

    IBD
  60. Benzinga's M&A Chatter for Tuesday January 20, 2015

    Benzinga
  61. Salix Pharmaceuticals

    IBD
  62. Report: Salix Pharmaceuticals Exploring Possible Sale

    Benzinga
  63. Salix Pharma Reportedly Exploring Sale; Stock Up

    IBD
  64. Jefferies Weighs In On Specialty Pharmaceuticals After Management ...

    Benzinga
  65. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  66. Stocks Mixed As Early Strength Fades; Salix Jumps

    IBD
  67. SALIX

    IBD
  68. Benzinga's M&A Chatter for Thursday December 18, 2014

    Benzinga
  69. Credit Suisse Raises Salix Pharmaceuticals Price Target

    Benzinga
  70. Salix rebounding from crash

    IBD
  71. Salix Destocking Plan, 2-Year Guidance Soothe Street

    IBD
  72. #PreMarket Movers From December 16, 2014

    Benzinga
  73. Pharmaceutical Giant Merck Buys Cubist Pharma

    GuruFocus
  74. Sterne Agee Says Salix Pharmaceuticals Accounting Concerns Are ...

    Benzinga
  75. How Adam Feuerstein Follows The Biotech Sector

    Benzinga
  76. Deutsche Bank Slashes Price Target On Salix Pharmaceuticals

    Benzinga
  77. U.S. Produced Fewer Than Expected Jobs In October

    Benzinga
  78. Health Sell-Offs Drag On IBD 50

    IBD
  79. Dow, S&P 500 Flirt With Record, But Finish Just Off

    IBD
  80. Stock Movers: Why Medicals Issues Are Dipping Today

    IBD
  81. Mid-Afternoon Market Update: Lions Gate Surges On Earnings Beat; ...

    Benzinga
  82. Midday Losers From November 7: Roka Bioscience, Salix Pharmaceuticals, ...

    Benzinga
  83. Mid-Day Market Update: Allscripts Healthcare Slides On Downbeat ...

    Benzinga
  84. Mid-Morning Market Update: Markets Edge Lower; Humana Profit ...

    Benzinga
  85. Jefferies Sees Acquisition Of Salix Pharmaceuticals As Being ...

    Benzinga
  86. Morning Market Losers

    Benzinga
  87. Benzinga's Top Downgrades

    Benzinga
  88. Stocks Set For Higher Start After Mixed Jobs Report

    IBD
  89. Stifel Nicolaus Downgrades Salix Pharmaceuticals To Hold

    Benzinga
  90. Benzinga's Top #PreMarket Losers

    Benzinga
  91. UPDATE: Stifel Downgrades Salix Pharmaceuticals As Uncovered ...

    Benzinga
  92. Salix Dives On Earnings, Probe; Akorn A Bad Seed Too

    IBD
  93. Salix Dives On Miss, Probe

    IBD
  94. Indexes Higher; El Pollo Loco Reports In Line

    IBD
  95. Stocks Cling To Modest Gains; Advance Auto Rebounds

    IBD
  96. Stocks Down As Early Gains Fade; Generac Dives, Tableau Soars

    IBD
  97. Earnings Scheduled For November 6, 2014

    Benzinga
  98. 3 IBD 50 Tech, Drug Stocks With Earnings Thursday

    IBD
  99. Salix, Skyworks Lead 6 IBD50 EarningsReports On Tap

    IBD
  100. Salix, Skyworks Lead 6 IBD 50 Earnings Reports On Tap

    IBD
Trading Center